
RBV Capital
Europe, Zug, Switzerland, Zug
Description
RBV Capital is a Zug-based life sciences VC firm established in 2014.
Investor Profile
RBV Capital has backed more than 9 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 44% of its total and boasts 2 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series C, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Russian Federation.
- Strong thematic focus on Health Care, Biotechnology, Therapeutics.
Stage Focus
- Series B (56%)
- Series C (11%)
- Series Unknown (11%)
- Series A (11%)
- Seed (11%)
Country Focus
- United States (56%)
- United Kingdom (22%)
- Russian Federation (22%)
Industry Focus
- Health Care
- Biotechnology
- Therapeutics
- Pharmaceutical
- Artificial Intelligence (Ai)
- Life Science
- Medical Device
- Software
- Clinical Trials
- Neuroscience
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.